Table 5 Demographic and clinical variables association with the IL-10 rs1800896 polymorphisms in IS patients.
From: Interleukins 10 and 1β gene polymorphisms in ischemic stroke risk in the Egyptian population
AA + GA n = 93 | GG n = 7 | Test (P) | p | ||
|---|---|---|---|---|---|
Gender | Male | 58 (62.4%) | 2 (28.6%) | χ2 = 3.098 | 0.112 |
Female | 35 (37.6%) | 5 (71.4%) | |||
High blood pressure | Absent | 28 (30.1%) | 2 (28.6%) | χ2 = 0.007 | 0.93 |
Present | 65 (69.9%) | 5 (71.4%) | |||
Smoking | Absent | 49 (52.7%) | 5 (71.4%) | χ2 = 0.920 | 0.337 |
Present | 44 (47.3%) | 2 (28.6%) | |||
DM | Absent | 46 (49.5%) | 2 (28.6%) | χ2 = 1.138 | 0.286 |
Present | 47 (50.5%) | 5 (71.4%) | |||
Consciousness issue | Absent | 25 (26.9%) | 3 (42.9%) | χ2 = 0.82 | 0.36 |
Present | 68 (73.1%) | 4 (57.1%) | |||
Chewing and swallowing trouble | Absent | 56 (60.2%) | 1 (14.3%) | χ2 = 5.60 | 0.018 |
Present | 37 (39.8%) | 6 (85.7%) | |||
